BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.740
-0.200 (-5.08%)
Aug 14, 2025, 11:27 AM - Market open
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $15.87 million as of August 14, 2025. Its market cap has decreased by -74.57% in one year.
Market Cap
15.87M
Enterprise Value
1.98M
1-Year Change
-74.57%
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $15.87M, a decrease of -53.05%. That is a compound annual growth rate of -4.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 15.87M | -32.43% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | 59.85M | 124.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 598.66B |
| Johnson & Johnson | 419.65B |
| AbbVie | 358.72B |
| UnitedHealth Group | 244.44B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.84B |